Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1Naomi Hunder, Cassian Yee, Herschel Wallen et al.|New England Journal of Medicine|2008Cited by 903
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityYared Hailemichael, Adi Diab, Daniel H. Johnson et al.|Cancer Cell|2022Cited by 338
Ultra-sensitive detection of rare T cell clonesHarlan Robins, Karen Cerosaletti, Cindy Desmarais et al.|Journal of Immunological Methods|2011Cited by 197
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Michael R. Green, Aaron Y. Chang et al.|Cancer Discovery|2020Cited by 159
Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor ImmunityYared Hailemichael, Adi Diab, Daniel H. Johnson et al.|SSRN Electronic Journal|2021Cited by 24